Literature DB >> 23961124

Effect of protease and helicase mutations on HCV NS3 activity.

Zaki Monawar Eisa1.   

Abstract

Hepatitis C virus (HCV) causes serious infections in the liver which may lead to liver cirrhosis and hepatocellular carcinoma. Non structural 3 (NS3) protein is one of the most important proteins of the virus which has protease and helicase activities. Protease activity has a crucial role in the replication and persistence of the virus. Site directed mutation was carried out in the protease region of one NS3 and another site directed mutation in the helicase region of another NS3. The expression of both mutated NS3 was compared with wild NS3. Expression of the three different NS3 types was confirmed by in situ staining and western blotting using an anti-NS3 antibody and correlated with a reduced antiviral response after treatment with interferon-α. Mutation analysis showed that the NS3 protease activity andnot the NS3 helicase was essential for the inhibition of the interferon-α response.

Entities:  

Keywords:  Hepatitis C virus (HCV); Non structural 3 (NS3)

Year:  2010        PMID: 23961124      PMCID: PMC3730570          DOI: 10.1016/j.sjbs.2010.09.001

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 1319-562X            Impact factor:   4.219


  18 in total

1.  The scientific challenge of hepatitis C.

Authors:  J Cohen
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

2.  Similarities in RNA helicases.

Authors:  E V Koonin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 4.  The chimpanzee model of hepatitis C virus infections.

Authors:  R E Lanford; C Bigger; S Bassett; G Klimpel
Journal:  ILAR J       Date:  2001

5.  Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.

Authors:  A D Wardell; W Errington; G Ciaramella; J Merson; M J McGarvey
Journal:  J Gen Virol       Date:  1999-03       Impact factor: 3.891

6.  Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.

Authors:  Adrien Breiman; Nathalie Grandvaux; Rongtuan Lin; Catherine Ottone; Shizuo Akira; Mitsutoshi Yoneyama; Takashi Fujita; John Hiscott; Eliane F Meurs
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Murine gammaherpesvirus 68 encodes a functional regulator of complement activation.

Authors:  S B Kapadia; H Molina; V van Berkel; S H Speck; H W Virgin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 8.  Hepatitis C virus infection: 10 years after the discovery of the virus.

Authors:  G Ramadori; V Meier
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 2.566

9.  NS3 is a serine protease required for processing of hepatitis C virus polyprotein.

Authors:  L Tomei; C Failla; E Santolini; R De Francesco; N La Monica
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more
  2 in total

1.  Construction and preparation of three recombinant adenoviruses expressing truncated NS3 and core genes of hepatitis C virus for vaccine purposes.

Authors:  Seyed Younes Hosseini; Farzaneh Sabahi; Seyed Mohammad Moazzeni; Mohammad Hossein Modarressi; Mehdi Saberi Firoozi; Mehrdad Ravanshad
Journal:  Hepat Mon       Date:  2012-08-14       Impact factor: 0.660

2.  HCV NS3 Blocking Effect on IFN Induced ISGs Like Viperin and IL28 With and Without NS4A.

Authors:  Zahra Khanlari; Farzaneh Sabahi; Seyed Younes Hosseini; Mostafa Ghaderi
Journal:  Hepat Mon       Date:  2014-06-08       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.